Most ‘Vaccinated’ Japan Brought to its Knees by Covid: Most Hospitalizations and Deaths - RAIR
FTA link....
...number of cases has so far remained at an average of 200,000 cases per day.
Worse, hospitalizations and Covid deaths have increased to a record level. Since January 4, 2023, hospitalizations have reached 44,101, surpassing the record set in August 2022, when 38,000 hospitalizations were reported in a single day.
As for the deaths, they suddenly increased to 489, reported on January 12, 2023. The graph of deaths in Japan shows an exponential increase with the mass vaccination of the population. Moreover, a pattern observed in official Covid reporting is that the most vaccinated countries also had the highest number of Covid infections. The most were registered in Austria, with 644,000 infections per million inhabitants, in South Korea, France, Portugal, Israel, and Denmark, with over 500,000 infections per million inhabitants, or in Australia, the Netherlands, and Slovakia, with over 400,000.
With nearly 250,000 cases per million people and a rapidly increasing number of infections, Japan will soon overtake these countries.
Comparatively, Romania and Bulgaria have low vaccination rates and around 170,000 infections per million inhabitants. Denmark, with over 500,000 infections per million inhabitants, or Australia, the Netherlands, and Slovakia, with over 400,000.
With nearly 250,000 cases per million people and a rapidly increasing number of infections, Japan will soon overtake these countries. Comparatively, Romania and Bulgaria have low vaccination rates and around 170,000 infections per million inhabitants.
Denmark, with over 500,000 infections per million inhabitants, or Australia, the Netherlands, and Slovakia, with over 400,000. With nearly 250,000 cases per million people and a rapidly increasing number of infections, Japan will soon overtake these countries.
Pfizer has informed the European authorities that it will continue the post-authorization studies of the Covid vaccine and will implement a pharmacovigilance plan. In this sense, support systems have been created to capture clinical data on the nature and severity of the Covid-19 disease in people who have received the Covid-19 mRNA vaccine, anticipating that these will provide insight into potential cases of lack of effect of the vaccine or side effects.
At the same time, the potential multisystem inflammatory syndrome in children and adults experienced by people following the administration of the Pfizer-BioNTech Covid-19 Vaccine will be studied. As additional pharmacovigilance actions, the manufacturer announces the conduct and follow-up of 20 safety and efficacy studies, of which five globally, 5 in Europe, 7 in the US, 2 in the US and Canada, and one each in New Zealand and Australia.
Seven of the announced studies will look at the incidence of myocarditis and pericarditis in the combined vaccine overall and stratified by age group, sex, race/ethnicity (if feasible), dose and risk interval. In addition, to assess the magnitude of risk, these studies will include comparative methods (self-controlled analyzes and analyzes involving a separate comparator group)....